Naomi Fried, PhD, is the founder and CEO of PharmStars. An internationally recognized thought leader in healthcare innovation, Naomi brings over two decades of expertise in digital health strategy and innovation, as well as an entrepreneurial spirit.

Naomi is also the co-founder and general partner of PharmStars Ventures Fund, a venture fund  which invests in PharmStars alumni companies. Previously, she was a general partner at the venture fund, Ambit Health Ventures, which invested in early-stage digital health and medical device startups. Naomi has served on a variety of startup boards of directors and advisory boards. Before founding PharmStars and Ambit, Naomi led a boutique consulting firm, Health Innovation Strategies, which advised pharma on digital health strategy and innovation activities.

Previously, Naomi was Biogen’s first VP of Innovation and External Partnerships, where she developed their “innovation beyond the molecule” strategy to deliver non-pharmacological value to patients and providers. Before her time at Biogen, Naomi served as the first Chief Innovation Officer at Boston Children’s Hospital and also the first VP of Innovation and Advanced Technology at Kaiser Permanente.

Naomi has been a member of the Governor of Massachusetts’ Innovation Council and the Board of the American Telemedicine Association. Her awards include Healthcare IT News’ “Health Information Technology (H.I.T.) Men and Women of the Year Award, Innovators.” Naomi was named “The Emerging Executive of the Year” in 2014 by the Massachusetts Technology Leadership Council and one of Medical Marketing and Media’s 40 “Healthcare Transformers” in 2016.

Naomi received her PhD in Materials Science from MIT and her BS in Chemistry, summa cum laude, from the University of California, Berkeley. When not working, Naomi can be found dancing up a storm in Zumba classes or lifting weights.

Dr. Shrawan Patel is the Head Mentor at PharmStars. Shrawan is a seasoned mentor with decades of experience in startups and pharma digital health. He has first-hand experience as a participant and mentor in multiple accelerators. Shrawan brings real-world business and technology acumen to the PharmStars program.

Shrawan is also the co-founder and general partner of PharmStars Ventures Fund, a venture fund  which invests in PharmStars alumni companies. He’s the Managing Director of Strategy Health, a boutique consulting firm that assists healthcare firms in making the most of emerging digital technologies. Previously, he was the Vice President of Clinical Transformation at RxHealth, which offers a digital health platform for prescribing and monitoring digital therapeutics. At RxHealth, he led the development and implementation of major partnerships with large pharma companies, serving as project lead and clinical lead for these partnerships. Alongside his role at RxHealth, Shrawan was the Clinical Transformation Lead at Mount Sinai’s digital health incubator, the AppLab.

Shrawan earned his MD in Medicine at Imperial College of London with a distinction in General Practice. He also holds a BS from Imperial College in Medical Science and Respiratory Science.

Shrawan enjoys playing sports and is a two-time US adult field hockey champion. He is also quite proficient with a sewing machine and enjoys outfitting himself, his family, and his house with his creations.

Meredith is PharmStars’ Program and Projects Manager. As a business consultant with more than 25 years of experience in organizational and professional development, Meredith brings expertise in strategic planning, project management, and client communication to her work on the program development and implementation of PharmaU.

Prior to PharmStars, she was the Planning and Projects Coordinator at Health Innovation Strategies, where she worked closely with clients on innovation challenge executions, including designing, building, and quality assurance testing the challenge websites.

In addition to her work in healthcare, Meredith has worked extensively in the creation and delivery of training programs for customers in the IT consulting industry. Meredith graduated magna cum laude from Brown University with a BA in Psychology.

Meredith loves the snow and if she had her way it would be winter all the time! In her free time, you can find her on the slopes, building a snowman, or dreaming of the next big blizzard.

Justine Dees, PhD is the Director of Marketing at PharmStars. A microbiologist-turned-life science marketer, she holds a PhD in microbiology from the University of Texas at Austin and has over a decade of experience spanning life science research, education, writing, communication, and the healthcare industry.

Before joining PharmStars, Justine founded a life science marketing consulting business, helping academic institutions and life science companies communicate their research and innovations with clarity and impact. As the creator of Joyful Microbe, an online platform dedicated to making microbiology accessible and engaging, Justine is a passionate advocate for science education and communication. She specializes in translating complex scientific concepts into clear, engaging content tailored for diverse audiences.

Prior to her transition into life science marketing and science communication, she conducted genomics and transcriptomics research on bacterial antimicrobial resistance and interspecies interactions during her PhD and postdoctoral studies. She also brings healthcare industry experience in microbiology quality control from her work at Covidien (Medtronic). Additionally, she served as a scientific laboratory manager at Daytona State College.

Outside of work, Justine loves exploring the outdoors, whether hiking, mountain biking, or setting off on road trips or aviation adventures with her husband. She’s always up for a scenic flight or a weekend getaway to a new spot. A serious coffee enthusiast, she enjoys French press and espresso. She also has a collection of over 50 houseplants and an undeniable love for cookies and chocolate.

Dr. Joanne Kamens is the Director of Alumni Programming at PharmStars. Joanne received her PhD in genetics from Harvard Medical School and has had a varied career in academia, pharma, biotech and nonprofit.

Joanne spent 15 years at BASF/Abbott (now AbbVie) as a scientist and group leader in basic research and then partner scouting for immunology indications. She then worked at RXi as Senior Director of Research Collaborations, directing scientists and coordinating research partnerships. After that she was the Executive Director/CEO of the international biotechnology nonprofit, Addgene, which was voted a ‘Best Place to Work in Boston’ for 6 years running and #1 Best Place in 2016.

Joanne is a leader in creating group mentoring programs and has been nominated for the Presidential Medal of Honor in STEM Mentoring.  She founded the Boston chapter of the Association for Women in Science (MASS AWIS).  Currently she is a diversity, equity & inclusion consultant, helping organizations develop processes and culture that support organizational success.

Joanne is an avid reader and relaxes with challenging crossword puzzles. She is currently working to master cryptic crosswords and is a level 50 Pokémon Go player.

Salomon (Sam) Azoulay is PharmStars Mentor Advisor and a pharma executive with more than 30 years of US and global experience. Sam has been recognized for his strategic and focused vision for successful implementation of creative plans that lead to optimizing organizational efficiency and portfolio development. He has a track record of worldwide regulatory approvals and successful launches of a broad portfolio of both innovative and established products. He has led large integrations and successfully transformed R&D organizations into lean, fit-for-purpose models to meet business needs.

Sam started his career in France with Hoechst Roussel and Pierre Fabre, moved to Roche, Switzerland and then to Parke Davis, UK. Following the Warner Lambert acquisition, he joined Pfizer US where he worked for 18 years in various executive positions. He was Head of R&D in Japan where he radically transformed the development process. He led the global cardio-metabolism division in the US where he changed the focus of the portfolio. He served as the Chief Medical Officer (CMO) of two major business units where he oversaw all development aspects of Pfizer assets.

Sam joined Roivant in 2018, where, as CMO, he contributed to the creation of five companies. Sam then served as Sumitovant’s CMO where he oversaw the portfolio development and numerous regulatory approvals in the US and was instrumental in the integration of two public companies.  Currently, Sam is the Chief Medical Officer at MBX Biosciences, a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.

Sam received an MD from Paris VI University with a specialization in Cardiology and a DESS (MBA) from La Sorbonne Paris. Sam enjoys traveling, reading, biking, and playing tennis but mostly loves spending time with his family, especially his four grandchildren.

Shwen Gwee is a PharmStars Mentor Advisor and is a recognized pioneer in digital health and health innovation. He has nearly 20 years of experience leading digital strategy and driving innovation in commercial, clinical, and enterprise-wide organizations, both on the client-side of biopharma and at creative agencies.

Shwen is the former Head of Global Digital Strategy at Bristol Myers Squibb (BMS), where he led digital strategy & innovation across the various business functions (R&D, Drug Development, Commercial and Manufacturing & Supply Chain) and established the enterprise strategy for digital medicines and therapeutics. Prior to BMS, he was the co-founder and Global Head of Open Innovation for the Novartis BIOME.

Shwen has also been involved in the health tech startup ecosystem for over 10 years and organizes startup events and pitch competitions regularly, including advising and running healthcare hackathons around the world as part of the MIT Hacking Medicine team.

He was named Top-40 “Healthcare Transformer” by MM&M in 2015, a PR Week "Health Influencer 50" in 2017 and 2018 and a Constellation Research "Business Transformation 150" in 2020. He sits on various advisory boards, including Google (Healthcare), SXSW (Health), MM&M Healthcare Transformers, conversationHEALTH, GRYT Health and the Digital Health Coalition.

In his free time, Shwen enjoys skiing, hiking, fishing, grilling and smoking meats, as well as camping with his son and his Boy Scout Troop.

Christi Hill is a PharmStars Mentor Advisor and the founder of Keystone Experience Initiative, an experience transformation and management consulting business. She also serves on several boards and commissions at the global and local level, allowing her to bring together her broad expertise and leadership within marketing, sales, and business strategy transformation across a multidimensional portfolio. She has extensive product launch, reorganization, and cross-functional integration experience with a focus on innovation and expanding the impact of proven approaches. Christi is a founding member of the Google Health Partner Council, Digital Health Coalition and has served on the Board of Advisors for a digital agency.

Before founding Keystone Experience Initiative, Christi worked as a trusted leader at Eli Lilly and Company for over 30 years. In her last role as a Corporate Strategy Vice President, she was responsible for developing and implementing enterprise-level customer experience strategy and foundational resources.  She also defined and led the culture transformation strategy, helping to catalyze explosive growth and success for Eli Lilly and Company.

Prior to joining Lilly, Christi worked as a project leader for Research Systems Corporation.  She graduated magna cum laude from Indiana State University, where she was named the ISU NCAA Student-Athlete of the Year and was a recipient of the G.O.L.D. (Graduate of the Last Decade) Award. Christi lives with her family in Carmel, Indiana, where she enjoys running, church activities, traveling, and visiting all the farmers’ markets she can.

Anna Kravets is a PharmStars Mentor Advisor and a healthcare technology leader with over 25 years of experience at the intersection of AI, public health, and enterprise strategy. She is president and Co-Founder of AdirA LLC and also serves as Chief Product & Technology Officer at Health and Travel. Her career includes senior roles at Merck as Chief Digital Officer of Health Services & Solutions, as Chief Information Officer of ILÚM Health Solutions, and as Chairwoman of the Industry Advisory Board at the NSF-sponsored ASSIST Center for nanotechnology and wearable health systems. Anna brings to PharmStars deep expertise in digital health strategy, pharma partnerships, and building AI-powered solutions that close the gap between patients and care. When she's not building, you'll find her hiking remote trails, exploring whisky regions in Scotland, or perfecting a brioche.

Amira Modi brings over 20 years of experience across pharmaceutical R&D, drug discovery services, healthcare technology, and private equity-backed healthcare businesses. As a Mentor Advisor to PharmStars, she leverages her experience as a COO, board member, and healthcare advisor to support emerging companies as they navigate growth, commercialization, strategic partnerships, and operational scale-up. Having worked across global pharma, CRO, health technology, and investor-backed organizations, she brings a multi-dimensional perspective on innovation and value creation across healthcare.

Amira is currently a Senior Advisor to multiple private equity firms, supporting healthcare and life sciences investments and portfolio value creation initiatives. Prior to this, she served as Chief Operating Officer and Board Member at Sygnature Discovery. Before Sygnature, she held senior leadership roles at IQVIA, overseeing a $200 million technology and services portfolio supporting pharmaceutical R&D and clinical development. Earlier in her career, she spent over a decade at GSK in commercial, finance, strategy, and operational leadership roles.

Amira holds a degree in Mathematics and Management from King's College London, an MSc in Accounting and Finance from the London School of Economics, and is a Chartered Accountant. She has also completed executive education programs at MIT Sloan and Harvard Medical School. In her spare time, Amira enjoys exploring the outdoors with her family, finding inspiration in nature, and pursuing creative interests that bring a different perspective to her work and leadership.

Marc Monseau is a PharmStars Mentor Advisor.  He has spent his professional career reaching, engaging, and influencing people through storytelling.

Marc started as a reporter for Bloomberg Business News in their London offices, with stints in Copenhagen and Stockholm as a political correspondent. After returning to the US, Marc worked as Bloomberg’s healthcare reporter, covering pharmaceutical, medical device, and biotechnology companies and the ongoing debate over healthcare reform.

After working at Bloomberg, Marc joined Johnson & Johnson’s corporate communications team, where he handled media relations, issues management, and crisis communications. He was also responsible for coordinating communications surrounding major acquisitions and investments. As a senior leader, Marc helped ensure customers, investors, employees, and the media knew the story of Johnson & Johnson, its products, and its people.

After leading Johnson & Johnson’s efforts to create a corporate social media presence, Marc established his own communications consultancy, Mint Collective. Through Mint Collective, Marc helps brands and businesses reach the right people at the right time with the right messages to achieve business results. When he’s not working with his clients, Marc splits his time between teaching at The College of New Jersey, gardening, and writing.

A resident of Princeton, NJ, where he lives with his wife Susanna and two cats, Marc holds a BA from Kenyon College and an MA from University College London.

Mark Niemaszek is a seasoned pharmaceutical executive with over 30 years of experience in financial management, commercial operations, and organizational leadership within the pharmaceutical industry. He currently serves as Senior Vice President, Commercial Excellence at Sumitomo Pharma America, where he oversees all operational functions supporting the Commercial and Market Access organizations.

In addition to his corporate role, Mr. Niemaszek is the President of OE Associates, LLC, where he has advised pharmaceutical companies for several years on strategic and operational initiatives. His career includes senior leadership positions at Urovant Sciences, where he was SVP of Strategic Planning and Commercial Operations, and at Astellas Pharma, where he served as Vice President of Commercial Operations and played a pivotal role in building the company’s domestic and global commercial operations capabilities. Earlier in his career, prior to the merger with Yamanouchi Pharmaceuticals, he held multiple leadership roles at Fujisawa Pharmaceuticals.

Throughout his career, Mr. Niemaszek has led critical functions including Corporate Finance, Global and U.S. Marketing & Sales Operations, Insights & Analytics, and Learning & Development, while also serving as Chair of the Pharmaceutical Commercial Operations Board. He continues to contribute to the industry as a Board Director and advisory member for several pharmaceutical technology, data, and analytics organizations. In his spare time, Mark likes to bike, golf and spend quality time traveling with his family.

Dhiren Patel is a PharmStars Mentor Advisor and seasoned healthcare executive with 15+ years of clinical and industry experience. Dhiren started his career as faculty at Brown University and Massachusetts College of Pharmacy.  While working at the Veterans Health Administration, he provided direct patient care to veterans with cardiovascular, renal, and metabolic conditions.

He has served as an investor and consultant to a variety of clients that include the federal government, biopharmaceutical companies, and digital health startups.  He joined Pack Health to start the medical affairs department in 2018. As Senior Vice President of Commercial, he oversaw sales, marketing, client success, and medical affairs at the company.

Dhiren completed his doctorate degree in Pharmacy at the Massachusetts College of Pharmacy, after which he went on to complete his post graduate residency training at the VA Boston Healthcare System. Dhiren has authored several textbooks, published numerous peer-reviewed journals, and delivered hundreds of presentations on behalf of the top 20 life sciences companies. Currently, Dhiren serves as a Co-Founder and Partner at Taurus Health.

In his free time, Dhiren enjoys traveling with his wife and their two kids, as well as watching sporting events live.

Steve Prewitt is a PharmStars mentor advisor.  He currently serves as an advisor and investor in the health tech space with leadership experience across biotech, pharma, healthcare and life sciences.

Steve served as Senior Vice President and Global Head of Digital Innovation at Sumitovant (a Roivant collaboration) and the Chief Analytics Officer at Healthfirst, a $10B New York City health plan.  Steve is on the advisory board of several tech startups. Previously he held leadership roles at Pfizer, Charles River Labs (a CRO), a home nursing provider, and PA Consulting Group.

Steve has a degree in Computer Science from Avila University in Kansas City and an MBA from Washington University in St. Louis.  He lives with his wife in New York City.  When he's not working, Steve can be found running, reading, traveling, or playing golf badly.

Dr. Veena Rao brings over 20 years of business and technical experience as a Mentor Advisor to PharmStars, leveraging her experiences in pharma, big tech, and digital health.  She has been actively working in early to late phase development projects from both the technical and commercial perspective in pharma, biotech, academia, and start-up settings— giving her a multi-dimensional perspective of new products in healthcare.

Veena is currently the Chief Business Officer for Portal Instruments, a device start-up.  Prior to Portal, she was the Chief Commercial Officer at Beta Bionics and prior to that, Vice President of External Innovation for Devices, Delivery, and Digital Health at Eli Lilly.  In her 13 years at Lilly, Veena held a number of commercial and R&D positions which provided her a broad understanding of the drug development and commercialization process.

Veena  is a Chemical Engineer by training and holds a PhD from Stanford University. She also earned an MBA from the Darden School at the University of Virginia.  In her spare time, Veena likes to go hiking and biking.

Paul Schmidt is a PharmStars Mentor Advisor and the Founder and CEO of Viventi Advisors, where he helps rare disease founders pressure-test their commercial assumptions before pharma does it for them.

Paul brings 13+ years in pharma and biotech, with 10+ focused specifically on rare disease, overseeing $50B+ in revenue operations and $5B+ in investment decisions. He spent five years at Alexion (AstraZeneca Rare Disease), first as Global Head of Commercial Finance, then as Chief of Staff to the CEO. Earlier, he held commercial finance leadership roles at Akcea Therapeutics, Gilead Sciences, and Intarcia Therapeutics.

Paul is also an angel investor with Launchpad Venture Group. His connection to rare disease is personal — he's watched a parent navigate the system firsthand. He holds an MBA from the University of Chicago Booth School of Business.

Outside of work, Paul has visited 45+ countries and is fluent in Spanish — though he'll be the first to tell you it's for ordering food, not closing deals.

Katherine Vandebelt is a Mentor Advisor at PharmStars. She is a seasoned executive with deep clinical research expertise in building efficient and effective divisions. She has experience transforming global organizations, streamlining operations, and growing a profitable start-up company. Katherine is passionate about introducing new and better experiences to make the clinical research ecosystem better for patients, health care professionals, sponsors, and regulators by unlocking the power of technology.

Prior to working with PharmStars, Katherine was the Global Vice President Clinical Innovation, Oracle Life Sciences for four and half years.  Katherine served as a content expert and workstream leader in collaborations with public health and government organizations to accelerate the development and distribution of COVID-19 vaccines, therapeutics, and diagnostic testing. Katherine explored the depths of innovation and human compassion in clinical research as host of the Latest Dose podcast.

Prior to Oracle, Katherine was the Chief Ecosystem Officer at Reify Health. Katherine developed and executed the ‘go to market’ strategy for pharmaceutical customers.  Katherine drove global product strategy taking in to account GDPR requirements and the diversity in country health systems.
‍
Prior to Reify, Katherine worked at Eli Lilly and Company, where she held leadership positions across several continents and departments including Clinical Operations, Statistical Sciences, Data Sciences and Solutions.  She completed her 30-year career as Global Head, Clinical Innovation with a focus on making clinical research accessible to patients and feasible for healthcare providers.  Katherine collaborated with small and large health tech companies to co-develop new solutions.
‍
Katherine has lived in both hemispheres of the world, enjoys all types of weather and the activities they offer.  If you are unable to reach her, she is busy making memories with her family and friends.

Jill Waldner is a PharmStars Mentor Advisor with over 20 years of experience spanning large pharmaceutical companies and early-stage, VC-backed ventures. She brings a wealth of knowledge in finance, strategy, and cross-functional leadership, having held positions in R&D, manufacturing, commercial, corporate strategy, and digital health. This diverse background provides her with a comprehensive understanding of the pharmaceutical value chain and a multi-dimensional perspective on the healthcare industry.

Most recently, Jill served as Vice President of Corporate Strategy and Development at Evidation Health. Prior to that, she spent nearly two decades at Eli Lilly and Company, where she held a variety of roles including leadership positions in commercial, manufacturing, and R&D.Based in Boston, Jill enjoys spending time with her family and friends and traveling.

Amir Zur is a Mentor Advisor at PharmStars. He is the former Head of R&D Products of Digital Health at Takeda Pharmaceuticals, where he led the digital portfolio and strategy to build R&D Digital Health products to improve outcomes and treatments to patients.

Previously he was the Head of Digital Health Products and Quality at Teva, where he led the teams that built a novel product from scratch. He established the digital processes needed to transform the company’s capabilities. The respiratory product received FDA approval and recognition as the first of its kind across the health-tech industry.

For more than 25 years, Amir has held leadership roles in the digital industry. He has worked at  large global companies including Intel and Perion as well as small and mid-size firms. Today, Amir helps digital health startups with go-to-market strategy, product development, regulatory strategy, product design, and preparing for pharma integration.

While Amir has shaped his career to focus on “hybrid” drugs (which combine technology and therapeutics), he has another “hybrid” approach as well. As a trained yoga teacher, he coaches business companies and schools to embrace “Yoga-thinking” as part of their decision making processes.

George is the former Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals. He was responsible for building the company’s Global Information Technology function that enables Alexion to serve patients and their families with rare diseases through the innovation, development, and commercialization of life-changing therapies.

A bio-pharma industry veteran with over 35 years of business, information technology and cyber-security experience, George and his team develop and implement innovative technology and enable data-driven insights across Alexion’s R&D, Commercial, Manufacturing Operations and Supply Chain functions.

Prior to joining Alexion, George served as Vice President and business line CIO for Merck and Co., where he led the large-scale merger integration of Merck/Schering-Plough across the IT and Shared Business Services organizations. George previously worked at Citibank, N.A.

George serves on the Board of Directors of Charles River Laboratories and the National Center for Women & Information Technology (NCWIT). He also serves on the Advisory Board of Sierra Ventures and Temple University’s Fox Business School. George holds a Bachelor of Science in Computer Science from New York Institute of Technology and completed the Executive Development Program at both Harvard and the Wharton School of Business.

George was named to Forbes CIO Next 2021 list that highlights top tech executives who are redefining the CIO role and driving game-changing innovation. In 2020, he was named a Global CIO of the Year finalist by the Boston CIO Leadership Association for demonstrating excellence in technology leadership.

George’s cut his innovative teeth as a DJ on the ground floor of the rap movement, while growing up in the Bronx through the late 70’s and golden age of rap/hip hop in the 80’s.   George signed under Rush Management in 1981, who managed popular up and comers at the time including Run-DMC, Kurtis Blow, Whodini and later LL Cool J.  He has several album and single credits in addition to film that he keeps a secret.

Omkar Kulkarni is the first chief innovation officer at Children’s Hospital Los Angeles. In his role, Omkar is responsible for fostering innovation across CHLA's clinical and research enterprises, including launching an enterprise virtual care program, incubating and implementing new digital health tools and medical devices, and rallying communities inside and out of the hospital to solve problems in the field of pediatrics. These efforts all share the goal of enhancing the experience and outcomes for the children and families CHLA serves. Omkar is also the Founder and Managing Director of KidsX, the first and only national pediatric digital health accelerator program.

Prior to joining CHLA, Omkar served as the Executive Director of the Cedars-Sinai Accelerator powered by Techstars, where he helped build and launch the accelerator program. In that role, he evaluated over 3,000 health care startups and provided extensive mentoring, serving as the main liaison between the startup community and Cedars-Sinai Medical Center. Omkar also led the performance improvement department at Cedars-Sinai for many years and has experience in financial process redesign at New York-Presbyterian Hospital. Omkar has a BA in business administration from George Washington University and an MA in public health and health care management from Columbia University.

Rachele Ryan is the Senior Director of Partnerships, Programming, & Community at LabCentral. In this role, she is responsible for business development strategy, resident company growth and development, and oversees all events and programming such as our social impact and educational initiatives.

Prior to joining LabCentral, Rachele led the MassCONNECT mentoring program at MassBio, the Massachusetts biopharma industry association. In that role, she matched life sciences entrepreneurs and founders with seasoned life sciences professionals to catalyze and commercialize innovation. Previously, as part of the International Business Development team at the Consulate General of Canada in Boston, she assisted Canadian companies with their expansion efforts into New England and supported fast-growing startups participating in the Canadian Technology Accelerator in Boston (CTA@Boston). Rachele holds a BA from College of the Holy Cross and an MA from Middlebury College.

Mohan Nair is an accomplished visionary and problem solver, serving as advisor, investor, company creator, entrepreneur, corporate executive, speaker and author. He is currently the Chief Executive of Emerge Inc., an advisory firm based on the principle that business transformation accelerates when companies and individuals are motivated by the greater good.

For 10 years prior, Mohan served as Chief Innovation Officer and Senior Vice President of Cambia Health Solutions. In this role, he transformed the internal culture, accelerating problems to solutions and creating and launching 6 startups in 10 years. For 7 years prior, Mohan was Chief Marketing Executive and Executive Vice President for Regence Blue Cross Blue Shield, leading all front-end functions for the multi-billion dollar firm.

Mohan was named Marketing Executive of the Year in 2009 by The Marketing Leadership Council. He has authored a book entitled Strategic Business Transformation: the 7 deadly sins to avoid as well as two other books and published over 15 refereed-journal articles on high-performance measurement and servant leadership. He publishes in Forbes.com and Ramaonhealthcare.com and is also a TED speaker.

Mohan has taught as an adjunct professor of business at JL Kellogg School of Management for 12 years. New Zealand awarded him the prestigious Edmund Hillary Fellowship and he is a healthcare advisor to MOVAC capital, the largest New Zealand venture fund and Caramed Capital, a fund focused on healthcare.

Mohan was a Singapore TV talk show host. He is a musician with 20 copyrighted songs and plays the bagpipes and the guitar. He is also the first healthcare executive to have auditioned for, and lost at, America's Got Talent.

Dr. Yan Chow brings his thought leadership and broad experience across healthcare, pharma, startups, and innovation to his role as the Special Advisor to PharmStars. With over 15 years of experience in large healthcare and biopharma enterprises and startup ventures, Yan has deep expertise on both “sides of the table.”

Yan is the Global Healthcare Industry Leader at Automation Anywhere, which is a pioneer in the robotic process automation industry. Previously, he was the Medical Director for Digital Medicine in the Translational Medicine group at Amgen, where he led efforts to investigate digital biomarkers and incorporate digital technologies such as wearable sensors, virtual studies, mobile apps, social media, and advanced analytics into clinical trials. Until 2014, Dr. Chow was the national Director of the Innovation & Advanced Technology Group (IAT) at Kaiser Permanente, which assessed and made recommendations about over 2,000 new and emerging clinical information technologies.
‍
Yan has founded and advised several startups. Yan was selected by Healthcare IT News (HIMSS) as a winner in the Innovator category of the 2014 H.I.T. Men & Women Awards. Yan earned his AB with honors from Harvard University and his MD from UC San Diego. In 2005 he received his MBA from UC Berkeley’s Haas Business School, where he graduated as valedictorian.

In his free time, Yan enjoys photography. He is also known to sneak in some occasional programming when he has a few spare minutes!